Nalaganje...
HBV replication inhibitors
Chronic Hepatitis B Virus infections afflict >250 million people and kill nearly 1 million annually. Current non-curative therapies are dominated by nucleos(t)ide analogs (NAs) that profoundly but incompletely suppress DNA synthesis by the viral reverse transcriptase. Residual HBV replication dur...
Shranjeno v:
| izdano v: | Antiviral Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7293572/ https://ncbi.nlm.nih.gov/pubmed/32380149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2020.104815 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|